Variant C677T in the methylenetetrahydrofolate reductase gene in patients with rheumatoid arthritis treated with methotrexate. Implication with an increase in the level of transaminases.

dc.contributorUniv Guadalajara, CUCS, Guadalajara 44430, Jalisco, Mexico
dc.creatorDavalos, IP
dc.creatorMena, JP
dc.creatorBanuelos-Gallo, D
dc.creatorSanchez-Hernandez, JD
dc.creatorSandoval, L
dc.creatorGonzalez-Lopez, L
dc.creatorGamez-Nava, JI
dc.creatorSalazar-Paramo, M
dc.date.accessioned2015-11-19T18:57:12Z
dc.date.accessioned2023-07-04T02:10:04Z
dc.date.available2015-11-19T18:57:12Z
dc.date.available2023-07-04T02:10:04Z
dc.date.created2015-11-19T18:57:12Z
dc.date.issued2006
dc.identifier0315-162X
dc.identifierhttp://hdl.handle.net/20.500.12104/70517
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7260537
dc.languageEnglish
dc.publisherJ RHEUMATOL PUBL CO
dc.relationJOURNAL OF RHEUMATOLOGY
dc.relation33
dc.relation2
dc.relation418
dc.relation418
dc.relationWOS
dc.titleVariant C677T in the methylenetetrahydrofolate reductase gene in patients with rheumatoid arthritis treated with methotrexate. Implication with an increase in the level of transaminases.
dc.typeMeeting Abstract


Este ítem pertenece a la siguiente institución